Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
70.47
+2.31 (+3.39%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
7,998,553
Open
69.50
Bid (Size)
70.56 (5)
Ask (Size)
70.80 (6)
Prev. Close
68.16
Today's Range
68.51 - 72.36
52wk Range
8.280 - 99.41
Shares Outstanding
99,581,693
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today
September 20, 2024
The prospects of the latter two companies looked better following the European pharmaceutical's new clinical trial readout.
Via
The Motley Fool
Jim Cramer: Viking Therapeutics Has 'Many Ships Coming In'
September 20, 2024
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
Via
Benzinga
Performance
YTD
+285.50%
+285.50%
1 Month
+9.51%
+9.51%
3 Month
+35.21%
+35.21%
6 Month
+1.85%
+1.85%
1 Year
+447.13%
+447.13%
More News
Read More
Viking Therapeutics Is Having a Year to Remember: Time to Buy?
September 19, 2024
Via
MarketBeat
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
September 18, 2024
Via
The Motley Fool
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
September 18, 2024
Via
The Motley Fool
What the Options Market Tells Us About Viking Therapeutics
September 17, 2024
Via
Benzinga
Viking Therapeutics Unusual Options Activity For September 11
September 11, 2024
Via
Benzinga
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $7,500 Today
September 06, 2024
Via
Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
Via
The Motley Fool
Missed Out on Viking Therapeutics? Buy This Weight Loss Biotech Stock Right Now.
September 15, 2024
Via
The Motley Fool
Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review
September 13, 2024
Via
Investor's Business Daily
These 2 Biotech Stocks Are Set to Soar
September 13, 2024
Via
The Motley Fool
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
September 13, 2024
Via
The Motley Fool
Why Investors Plowed Into Viking Therapeutics Stock Today
September 12, 2024
Via
The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
September 12, 2024
Via
The Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
September 11, 2024
Via
The Motley Fool
Viking Therapeutics Stock Could Soar 45% Ahead Of Key Weight Loss Drug Readout: JPMorgan
September 11, 2024
Via
Benzinga
Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise
September 11, 2024
Via
Investor's Business Daily
Billionaires Are Buying Viking Therapeutics Stock Left and Right. Should You Follow Their Lead?
September 07, 2024
Via
The Motley Fool
Fake Ozempic Targets Weight-Loss Market: Forged Batches An International Concern
September 05, 2024
Via
Benzinga
Prediction: This Biotech Stock Will Outperform Nvidia in the Second Half of the Year
September 05, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
The Best Biotech Stock to Invest $1,000 in Right Now
September 03, 2024
Via
The Motley Fool
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
August 29, 2024
Via
Investor's Business Daily
Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics
August 29, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.